Risk Factors of Hypersensitivity to Carboplatin in Patients with Gynecologic Malignancies

We evaluated the prevalence of and risk factors for hypersensitivity reactions related to carboplatin, which is commonly used to treat gynecological malignancies. All women with pathologically documented ovarian, fallopian tube, or primary peritoneal cancer treated with carboplatin alone or a carbop...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Front Pharmacol
Main Authors: Tai, Yu-Hsiao, Tai, Yi-Jou, Hsu, Heng-Cheng, Lee, Shu-Ping, Chen, Yun-Yuan, Chiang, Ying-Cheng, Chen, Yu-Li, Chen, Chi-An, Cheng, Wen-Fang
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2017
Teme:
Pharmacology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5681487/
https://ncbi.nlm.nih.gov/pubmed/29163180
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2017.00800
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki